Cargando…
Safety and Efficacy of Intravenous and Intrathecal Delivery of AAV9-Mediated ARSA in Minipigs
Metachromatic leukodystrophy (MLD) is a hereditary neurodegenerative disease characterized by demyelination and motor and cognitive impairments due to deficiencies of the lysosomal enzyme arylsulfatase A (ARSA) or the saposin B activator protein (SapB). Current treatments are limited; however, gene...
Autores principales: | Mullagulova, Aysilu, Shaimardanova, Alisa, Solovyeva, Valeriya, Mukhamedshina, Yana, Chulpanova, Daria, Kostennikov, Alexander, Issa, Shaza, Rizvanov, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253118/ https://www.ncbi.nlm.nih.gov/pubmed/37298156 http://dx.doi.org/10.3390/ijms24119204 |
Ejemplares similares
-
Increasing β-hexosaminidase A activity using genetically modified mesenchymal stem cells
por: Shaimardanova, Alisa A., et al.
Publicado: (2023) -
Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches
por: Shaimardanova, Alisa A., et al.
Publicado: (2020) -
Gene and Cell Therapy for Epilepsy: A Mini Review
por: Shaimardanova, Alisa A., et al.
Publicado: (2022) -
Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
por: Issa, Shaza S., et al.
Publicado: (2023) -
Gene Therapy of Sphingolipid Metabolic Disorders
por: Shaimardanova, Alisa A., et al.
Publicado: (2023)